Pemgem - Pemetrexed 100 mg Inj

Pemetrexed is an antimetabolite chemotherapy medicine containing pemetrexed as the active ingredient. It is administered by intravenous infusion under the supervision of an experienced oncology healthcare professional. It is commonly used for certain patients with non-small cell lung cancer and malignant pleural mesothelioma, depending on the treatment regimen. Pemetrexed interferes with several folate-dependent enzymes involved in DNA and RNA production, helping slow the growth of cancer cells. Folic acid and vitamin B12 supplementation are generally given with pemetrexed to reduce certain treatment-related toxicities. Common adverse effects may include fatigue, nausea, vomiting, loss of appetite, anemia, and reduced blood cell counts. Kidney function and blood counts are typically monitored during treatment because the medicine can cause serious toxicity in some patients. The appropriate dose and treatment schedule depend on the cancer type, body measurements, kidney function, and the overall treatment plan.